Pleural Effusion in End-Stage Renal Disease

Epidemiology and Clinical Significance

The European Respiratory Society reports that pleural effusions occur in approximately 21-25% of hospitalized ESRD patients, making this a frequent complication to actively screen for 1, 2
The presence of pleural effusion in ESRD patients carries grave prognostic implications, with 6-month and 1-year mortality rates of 31% and 46% respectively—three times higher than the general ESRD population 3
Most patients experience significant dyspnea and symptom burden, warranting a palliative approach in many cases 3

Fluid overload is the most common cause of pleural effusion in ESRD patients, accounting for 61.5% of cases, according to the European Respiratory Society 2, 1
The European Respiratory Society identifies heart failure as a distinct cause, accounting for 9.6% of cases, often coexisting with fluid overload 2
Hypoalbuminemia, secondary to nephrotic syndrome, is another cause, leading to decreased oncotic pressure 1, 2

The European Respiratory Society recommends obtaining cross-sectional imaging (CT chest) early when clinical suspicion exists for infection or malignancy, rather than waiting for thoracentesis results 3
When performing thoracentesis, check pleural fluid glucose, as markedly elevated levels (>serum) suggest a peritoneal dialysis-associated leak 1, 3
Check the pleural fluid creatinine/serum creatinine ratio, as a ratio >1 indicates urinothorax 1, 3

The European Respiratory Society recommends first-line treatment as intensifying renal replacement therapy, not pleural intervention 2, 3
Serial thoracentesis provides equivalent symptomatic relief to indwelling pleural catheters and should be the preferred initial pleural intervention, according to the European Respiratory Society 2, 3
Consider indwelling pleural catheter (IPC) for patients requiring ≥3 therapeutic thoracenteses, as IPCs show significant dyspnea improvement without significant albumin loss in ESRD patients 3

The European Respiratory Society recommends prioritizing symptom palliation and quality of life over aggressive interventions, given the extremely frail condition and dismal prognosis of ESRD patients with pleural effusions 3
Early involvement of palliative care teams is appropriate for refractory effusions, as treatments are frequently for palliative intent 3